Correction: Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants.

MLA

Greulich, Heidi, et al. “Correction: Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants.” PLoS Medicine, vol. 21, no. 9, Sept. 2024, p. e1004470. EBSCOhost, https://doi.org/10.1371/journal.pmed.1004470.

APA

Greulich, H., Chen, T.-H., Feng, W., Jänne, P. A., Alvarez, J. V., Zappaterra, M., Bulmer, S. E., Frank, D. A., Hahn, W. C., Sellers, W. R., & Meyerson, M. (2024). Correction: Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants. PLoS Medicine, 21(9), e1004470. https://doi.org/10.1371/journal.pmed.1004470

Chicago

Greulich, Heidi, Tzu-Hsiu Chen, Whei Feng, Pasi A Jänne, James V Alvarez, Mauro Zappaterra, Sara E Bulmer, et al. 2024. “Correction: Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants.” PLoS Medicine 21 (9): e1004470. doi:10.1371/journal.pmed.1004470.